Alice Ho, Ph.D., Senior Associate, Arnold & Porter Kaye Scholer LLP to Speak at The Knowledge Double Patenting in the USPTO Era
The Knowledge Group, the leading producer of regulatory-focused webcasts, has announced today that Alice Ho, Ph.D., Senior Associate, Arnold & Porter Kaye Scholer LLP will speak at its webcast entitled, “Navigating Double Patenting in the USPTO Era of Rulemaking.”
- (1888PressRelease) February 10, 2025 - This event is scheduled for Tuesday, February 25, 2025, from 12:00 PM to 1:30 (ET).
For further details, please visit:
https://knowledgewebcasts.com/know-portfolio/navigating-double-patenting-in-the-uspto-era-of-rulemaking/
About Alice Ho, Ph.D.
Dr. Alice Ho is an intellectual property attorney with Arnold & Porter in Washington, D.C. With a focus on biotechnology, medical device, pharmaceutical, and life sciences companies, Dr. Ho's practice includes patent prosecution, handling matters before the Patent Trial and Appeal Board, Hatch-Waxman litigation, and other litigation before Federal District courts, as well as advising on the intellectual property aspects of transactions. Dr. Ho received her Ph.D. from The Johns Hopkins University School of Medicine. She has been recognized by LMG Life Sciences and Legal 500, and she is an active member of the PTAB Bar Association, serving as a Committee Vice Chair of the Women’s Committee.
About Arnold & Porter Kaye Scholer LLP
Arnold & Porter combines sophisticated regulatory, litigation, and transactional capabilities to resolve clients’ most complex issues. With over 1,000 lawyers practicing in 15 offices worldwide, we offer deep industry experience and an integrated approach that spans more than 40 practice areas. Through multidisciplinary collaboration and focused industry experience, we provide innovative and effective solutions to mitigate risks, address challenges, and achieve successful outcomes.
Event Summary
In today’s evolving patent landscape, understanding obviousness-type double patenting (ODP) is critical to securing and maintaining strong intellectual property rights. The Federal Circuit's evolving case law in the URAA era from Gilead to Novartis, and most recently Cellect and Allergan has significant implications for patent protection strategies.
Join our speakers in this CLE webcast as they explore the latest developments in double patenting jurisprudence and share strategic insights to mitigate risks and optimize patent prosecution. The discussion will cover proactive measures such as removing unnecessary terminal disclaimers before issuance, leveraging patent term extension (PTE), and addressing the risk of ODP to patent term adjustment (PTA). It will also highlight key prosecution strategies, IP portfolio audits to identify potential ODP challenges, and the use of reissue applications to correct PTA-related vulnerabilities.
Key topics to be discussed:
- Background of double patenting and Federal Circuit case law (Gilead, Novartis, Cellect, Allergan)
- Preemptive strategies to avoid unnecessary terminal disclaimers
- ODP implications on PTA and PTE protection
- Holistic prosecution approaches to mitigate ODP risks
- Best practices for auditing IP portfolios and addressing ODP challenges
- Reissue applications as a tool for patents with PTA
- Global IP strategy considerations for US national stage entry
- Decision-making authority in licenses and collaboration agreements
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
Contact:
Therese Lumbao
Director, Account Management & Member Services
The Knowledge Group, LLC
info ( @ ) theknowledgegroup dot org
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam